Ju Liu
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Toll-like receptor 4 signalling regulates antibody response to adenoviral vector-based vaccines by imprinting germinal centre quality.
Journal: Immunology
Published: February 21, 2018
Identification of antigen-specific human monoclonal antibodies using high-throughput sequencing of the antibody repertoire.
Journal: Biochemical and biophysical research communications
Published: February 26, 2016
Recombinant HSA-CMG2 Is a Promising Anthrax Toxin Inhibitor.
Journal: Toxins
Published: October 30, 2015
Quantitative Determination of Lethal Toxin Proteins in Culture Supernatant of Human Live Anthrax Vaccine Bacillus anthracis A16R.
Journal: Toxins
Published: October 27, 2015
Generation and Characterization of Human Monoclonal Antibodies Targeting Anthrax Protective Antigen following Vaccination with a Recombinant Protective Antigen Vaccine.
Journal: Clinical and vaccine immunology : CVI
Published: December 10, 2014
Intramuscular delivery of adenovirus serotype 5 vector expressing humanized protective antigen induces rapid protection against anthrax that may bypass intranasally originated preexisting adenovirus immunity.
Journal: Clinical and vaccine immunology : CVI
Published: December 06, 2013
Secretory expression and efficient purification of recombinant anthrax toxin lethal factor with full biological activity in E. coli.
Journal: Protein expression and purification
Published: January 03, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026